Luxna Biotech Co., Ltd.
- Medical Engineering & Biotechnology
Corporate Number｜7120901039358
Luxna Biotech is a preclinical stage antisense drug development company. Our technologies are consisted by novel modified nucleosides invented by Osaka University and original drug development platform called LuxiAPTM. We have been extensively ASO drug discovery cooperative development with several pharmaceutical companies and academic labs for multiple targets. In particular, in the area of neurological disorders, we are energetically working on the realization of multiple tie-ups and the in-house development of spinal cord injury treatment drugs.
